Cytokine immunomodulator

This page covers all Cytokine immunomodulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GM-CSF receptor (CD116/CD131).

Targets

GM-CSF receptor (CD116/CD131)

Phase 3 pipeline (1)

• GM-CSF priming · Eastern Cooperative Oncology Group · Oncology
  GM-CSF priming enhances immune cell activation and recruitment by stimulating granulocyte-macrophage colony-stimulating factor signaling to prime myeloid cells for improved anti-tumor immunity.

Patent intelligence

• cytokine immunomodulator patent landscape — aggregated cliff calendar, attackable patents, originator estates